1. Home
  2. SILO vs BREA Comparison

SILO vs BREA Comparison

Compare SILO & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • BREA
  • Stock Information
  • Founded
  • SILO 2010
  • BREA 2022
  • Country
  • SILO United States
  • BREA Ireland
  • Employees
  • SILO N/A
  • BREA N/A
  • Industry
  • SILO Apparel
  • BREA Services-Misc. Amusement & Recreation
  • Sector
  • SILO Consumer Discretionary
  • BREA Consumer Discretionary
  • Exchange
  • SILO Nasdaq
  • BREA Nasdaq
  • Market Cap
  • SILO 8.8M
  • BREA 8.7M
  • IPO Year
  • SILO N/A
  • BREA 2023
  • Fundamental
  • Price
  • SILO $1.66
  • BREA $0.65
  • Analyst Decision
  • SILO
  • BREA
  • Analyst Count
  • SILO 0
  • BREA 0
  • Target Price
  • SILO N/A
  • BREA N/A
  • AVG Volume (30 Days)
  • SILO 9.1M
  • BREA 104.1K
  • Earning Date
  • SILO 02-14-2025
  • BREA 01-03-2025
  • Dividend Yield
  • SILO N/A
  • BREA N/A
  • EPS Growth
  • SILO N/A
  • BREA N/A
  • EPS
  • SILO N/A
  • BREA N/A
  • Revenue
  • SILO $72,102.00
  • BREA $2,872,101.00
  • Revenue This Year
  • SILO $1.86
  • BREA N/A
  • Revenue Next Year
  • SILO N/A
  • BREA N/A
  • P/E Ratio
  • SILO N/A
  • BREA N/A
  • Revenue Growth
  • SILO N/A
  • BREA 2338.69
  • 52 Week Low
  • SILO $0.77
  • BREA $0.50
  • 52 Week High
  • SILO $4.50
  • BREA $3.00
  • Technical
  • Relative Strength Index (RSI)
  • SILO 52.57
  • BREA 40.04
  • Support Level
  • SILO $1.56
  • BREA $0.62
  • Resistance Level
  • SILO $1.89
  • BREA $0.69
  • Average True Range (ATR)
  • SILO 0.19
  • BREA 0.05
  • MACD
  • SILO -0.05
  • BREA -0.01
  • Stochastic Oscillator
  • SILO 27.12
  • BREA 15.31

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

Share on Social Networks: